» Articles » PMID: 32010692

Crosstalk Between Acid Sphingomyelinase and Inflammasome Signaling and Their Emerging Roles in Tissue Injury and Fibrosis

Overview
Specialty Cell Biology
Date 2020 Feb 4
PMID 32010692
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammasomes are a group of protein complexes that are assembled by pattern recognition receptors following the recognition of invading pathogens or host-derived danger signals. Inflammasomes such as NLRP3 mediate the activation of caspase-1 and the production of the proinflammatory cytokines IL-18 and IL-1β. Regulation of inflammasome signaling is critical for host defense against infections and maintenance of cellular homeostasis upon exposure to multiple harmful stimuli. Recent studies have highlighted an important role of acid sphingomyelinase (ASM) in regulating inflammasome activation. ASM hydrolyzes sphingomyelin to ceramide, which further fuses to large ceramide-enriched platforms functioning in stabilizing and amplifying molecules and receptors. Here, we will discuss the current understanding of the ASM-ceramide system in inflammasome activation, and how it contributes to multiple diseases. Insights into such mechanisms would pave the way for further exploration of novel diagnostic, preventative, and therapeutic targets against tissue injury and fibrosis.

Citing Articles

Ceramides As Potential New Predictors of the Severity of Acute Coronary Syndrome in Conjunction with SARS-CoV-2 Infection.

Lozhkina N, Gushchina O, Basov N, Gaisler E, Rogachev A, Sotnikova Y Acta Naturae. 2024; 16(2):53-60.

PMID: 39188263 PMC: 11345093. DOI: 10.32607/actanaturae.27400.


Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation.

Al-Rashed F, Arefanian H, Madhoun A, Bahman F, Sindhu S, Alsaeed H Cells. 2024; 13(5).

PMID: 38474427 PMC: 10931069. DOI: 10.3390/cells13050463.


Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer's disease.

Choi B, Park M, Jin H, Bae J Exp Mol Med. 2024; 56(2):301-310.

PMID: 38337058 PMC: 10907607. DOI: 10.1038/s12276-024-01176-4.


The relevance of acid sphingomyelinase as a potential target for therapeutic intervention in hepatic disorders: current scenario and anticipated trends.

Mir I, Thirunavukkarasu C Arch Toxicol. 2023; 97(8):2069-2087.

PMID: 37248308 PMC: 10226719. DOI: 10.1007/s00204-023-03529-w.


Acid Sphingomyelinase Inhibitor, Imipramine, Reduces Hippocampal Neuronal Death after Traumatic Brain Injury.

Lee S, Kho A, Lee S, Hong D, Kang B, Park M Int J Mol Sci. 2022; 23(23).

PMID: 36499076 PMC: 9740309. DOI: 10.3390/ijms232314749.


References
1.
Fowler S . Lysosomal localization of sphingomyelinase in rat liver. Biochim Biophys Acta. 1969; 191(2):481-4. DOI: 10.1016/0005-2744(69)90271-x. View

2.
Schissel S, Jiang X, Jeong T, Camejo E, Najib J, Rapp J . Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem. 1998; 273(5):2738-46. DOI: 10.1074/jbc.273.5.2738. View

3.
Jin S, Zhou F . Lipid raft redox signaling platforms in vascular dysfunction: features and mechanisms. Curr Atheroscler Rep. 2009; 11(3):220-6. DOI: 10.1007/s11883-009-0034-6. View

4.
He Y, Hara H, Nunez G . Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci. 2016; 41(12):1012-1021. PMC: 5123939. DOI: 10.1016/j.tibs.2016.09.002. View

5.
Abais J, Zhang C, Xia M, Liu Q, Gehr T, Boini K . NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxid Redox Signal. 2012; 18(13):1537-48. PMC: 3613176. DOI: 10.1089/ars.2012.4666. View